Australia Stock Exchange release from NUHEARA : Nuheara Clinical Trial and FDA 510(K) Pathway Update
24/11/2021 23:13
Australia Stock Exchange release from NUHEARA NUH.AX : Nuheara Clinical Trial and FDA 510(K) Pathway Update
NUH — Nuheara News Story
0.000.00%
Last trade - 00:00TechnologySpeculativeMicro Cap